Injectable Immunotherapy Offers Faster Cancer Treatment Option

Thousands of cancer patients may soon benefit from a new injectable form of immunotherapy. The formulation allows for significantly faster drug delivery.

Currently, immunotherapy treatments often require hours of intravenous infusion. The new injectable method reduces the treatment time to just minutes. This offers a more convenient and potentially less stressful experience for patients.

Researchers are continuing to study the effects of the treatment, although limited, initial results are promising.